Fluoxetine versus other types of pharmacotherapy for depression

Fluoxetine versus other types of pharmacotherapy for depression

Εμφάνιση άλλων εκδόσεων (2)

Background: Depression is common in primary care and it is associated with marked personal, social and economic morbidity, and creates significant demands on service providers in terms of workload. Treatment is predominantly pharmaceutical or psychological. Fluoxetine, the first of a group of antide...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Cipriani, A, Brambilla, P, Furukawa, T, Geddes, J, Gregis, M, Hotopf, M, Malvini, L, Barbui, C
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2009

Παρόμοια τεκμήρια

Fluoxetine versus other types of pharmacotherapy for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2005)

Fluoxetine versus other types of pharmacotherapy for depression
ανά: Magni, L, κ.ά.
Έκδοση: (2013)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2006)

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
ανά: Brambilla, P, κ.ά.
Έκδοση: (2005)

International dosage differences in fluoxetine clinical trials.
ανά: Patten, S, κ.ά.
Έκδοση: (2005)

Pharmacotherapy of adolescent depression - fluoxetine monotherapy or combined treatment?
ανά: Cesneková D., κ.ά.
Έκδοση: (2017-09-01)

Duloxetine versus other anti-depressive agents for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2012)

Paroxetine versus other anti-depressive agents for depression
ανά: Purgato, M, κ.ά.
Έκδοση: (2014)

Citalopram versus other anti-depressive agents for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2012)

Mirtazapine versus other antidepressive agents for depression.
ανά: Watanabe, N, κ.ά.
Έκδοση: (2011)

Fluvoxamine versus other anti-depressive agents for depression.
ανά: Omori, I, κ.ά.
Έκδοση: (2010)

Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2007)

Escitalopram versus other antidepressive agents for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2009)

Fluoxetine and amitriptyline: First-line treatments or reference compounds?
ανά: Barbui, C, κ.ά.
Έκδοση: (2004)

Milnacipran versus other antidepressive agents for depression.
ανά: Nakagawa, A, κ.ά.
Έκδοση: (2009)

Sertraline versus other antidepressive agents for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2009)

Sertraline versus other antidepressive agents for depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2010)

Sertraline versus other antidepressive agents for depression
ανά: Cipriani, A, κ.ά.
Έκδοση: (2010)

Long-term treatment of depression with antidepressants: a systematic narrative review.
ανά: Furukawa, T, κ.ά.
Έκδοση: (2007)

Depressive disorder needs an evidence base commensurate with its public health importance.
ανά: Geddes, J, κ.ά.
Έκδοση: (2007)

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2008)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2007)

Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children
ανά: Mari S. Golub, κ.ά.
Έκδοση: (2018-02-01)

"Wish bias" in antidepressant drug trials?
ανά: Barbui, C, κ.ά.
Έκδοση: (2004)

Venlafaxine for major depression.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2007)

Suicide, depression, and antidepressants.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2005)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
ανά: Watanabe, N, κ.ά.
Έκδοση: (2008)

Validity of the impact factor of journals as a measure of randomized controlled trial quality.
ανά: Barbui, C, κ.ά.
Έκδοση: (2006)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
ανά: Cipriani, A, κ.ά.
Έκδοση: (2005)

A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression
ανά: Cuijpers, P, κ.ά.
Έκδοση: (2020)

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
ανά: Barbui, C, κ.ά.
Έκδοση: (2008)

Fluoxetine improves minor depressive disorders.
ανά: Cowen, P
Έκδοση: (2005)

Ongoing pharmacotherapy maintains quality of life benefits in older adults with major depression.
ανά: Natarajan, M, κ.ά.
Έκδοση: (2008)

Depression in adults: drug and physical treatments.
ανά: Cipriani, A, κ.ά.
Έκδοση: (2011)

Depression in adults: drug and physical treatments.
ανά: Barbui, C, κ.ά.
Έκδοση: (2007)

SSRIs versus other antidepressants for depressive disorder.
ανά: Geddes, J, κ.ά.
Έκδοση: (2000)

Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
ανά: Nosè, M, κ.ά.
Έκδοση: (2006)

Psychologic treatment of depression compared with pharmacotherapy and combined treatment in primary care: a network meta-analysis
ανά: Cuijpers, P, κ.ά.
Έκδοση: (2021)

Imputing response rates from means and standard deviations in meta-analyses.
ανά: Furukawa, T, κ.ά.
Έκδοση: (2005)

Imputing missing standard deviations in meta-analyses can provide accurate results.
ανά: Furukawa, T, κ.ά.
Έκδοση: (2006)